CA2329569C - Methode d'essai de medicaments pour maintenir, ou eviter la perte ou permettre de retrouver les fonctions des cellules nerveuses - Google Patents

Methode d'essai de medicaments pour maintenir, ou eviter la perte ou permettre de retrouver les fonctions des cellules nerveuses Download PDF

Info

Publication number
CA2329569C
CA2329569C CA002329569A CA2329569A CA2329569C CA 2329569 C CA2329569 C CA 2329569C CA 002329569 A CA002329569 A CA 002329569A CA 2329569 A CA2329569 A CA 2329569A CA 2329569 C CA2329569 C CA 2329569C
Authority
CA
Canada
Prior art keywords
somata
deprenyl
mptp
loss
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002329569A
Other languages
English (en)
Other versions
CA2329569A1 (fr
Inventor
William G. Tatton
Carol E. Greenwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Toronto
Original Assignee
University of Toronto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Toronto filed Critical University of Toronto
Priority claimed from CA002107552A external-priority patent/CA2107552C/fr
Publication of CA2329569A1 publication Critical patent/CA2329569A1/fr
Application granted granted Critical
Publication of CA2329569C publication Critical patent/CA2329569C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002329569A 1991-04-04 1992-03-31 Methode d'essai de medicaments pour maintenir, ou eviter la perte ou permettre de retrouver les fonctions des cellules nerveuses Expired - Fee Related CA2329569C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US67887391A 1991-04-04 1991-04-04
US678,873 1991-04-04
US75118691A 1991-08-26 1991-08-26
US751,186 1991-08-26
US77291991A 1991-10-08 1991-10-08
US772,919 1991-10-08
CA002107552A CA2107552C (fr) 1991-04-04 1992-03-31 Utilisation du deprenyl pour le maintien, la prevention de la perte et la recuperation de la fonction nerveuse

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002107552A Division CA2107552C (fr) 1991-04-04 1992-03-31 Utilisation du deprenyl pour le maintien, la prevention de la perte et la recuperation de la fonction nerveuse

Publications (2)

Publication Number Publication Date
CA2329569A1 CA2329569A1 (fr) 1992-10-05
CA2329569C true CA2329569C (fr) 2007-06-05

Family

ID=27427090

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002329569A Expired - Fee Related CA2329569C (fr) 1991-04-04 1992-03-31 Methode d'essai de medicaments pour maintenir, ou eviter la perte ou permettre de retrouver les fonctions des cellules nerveuses

Country Status (1)

Country Link
CA (1) CA2329569C (fr)

Also Published As

Publication number Publication date
CA2329569A1 (fr) 1992-10-05

Similar Documents

Publication Publication Date Title
US5444095A (en) Use of deprenyl to rescue damaged nerve cells
US5844003A (en) Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
CA2107552C (fr) Utilisation du deprenyl pour le maintien, la prevention de la perte et la recuperation de la fonction nerveuse
Beal et al. Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice
Stacpoole et al. Clinical pharmacology and toxicology of dichloroacetate.
Hastings Enzymatic oxidation of dopamine: the role of prostaglandin H synthase
Di Monte et al. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys
Loeffler et al. Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidation
Liu et al. Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopa
US5767164A (en) Use of deprenyl to rescue damaged nerve cells
Seidler et al. Development of central control of norepinephrine turnover and release in the rat heart: responses to tyramine, 2-deoxyglucose and hydralazine
Smeraldi et al. Tryptophan depletion in obsessive-compulsive patients
Kappy et al. Adult-level insulin binding is present in term fetal rat CNS membranes
Eldrup Significance and origin of DOPA, DOPAC, and dopamine-sulphate in plasma, tissues and cerebrospinal fluid
Dési et al. Neurotoxicologic studies of two carbamate pesticides in subacute animal experiments
Lerner et al. Dopamine-β-hydroxylase and norepinephrine in human cerebrospinal fluid: effects of monoamine oxidase inhibitors
CA2329569C (fr) Methode d'essai de medicaments pour maintenir, ou eviter la perte ou permettre de retrouver les fonctions des cellules nerveuses
Udenfriend Biochemistry of serotonin and other indoleamines
Clow et al. Pergolide can induce soluble superoxide dismutase in rat striata
Wood et al. Effect of di-n-propylacetate and γ-acetylenic GABA on hyperbaric oxygen-induced seizures and GABA metabolism
US20020132829A1 (en) Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
Slotkin et al. Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
Karoum et al. Pemoline and urinary excretion of catecholamines and indoleamines in children with attention deficit disorder
Stenström et al. Comparison of Intra‐and Extrasynaptosomal Monoamine Oxidase‐A and‐B Activities in the Striatum and Frontal Cortex of Two Mice Strains with Different Sensitivities to the Neurotoxic Actions of 1‐Methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine
Luchins Biogenic amines and affective disorders

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed